An integrated national scale SARS-CoV-2 genomic surveillance network

The COVID-19 Genomics UK (COG-UK) Consortium, Darren Smith, Matthew Bashton

Research output: Contribution to journalComment/debatepeer-review

155 Citations (Scopus)
65 Downloads (Pure)


The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
Original languageEnglish
Pages (from-to)E99-E100
JournalThe Lancet Microbe
Issue number1
Early online date2 Jun 2020
Publication statusPublished - 1 Jul 2020


Dive into the research topics of 'An integrated national scale SARS-CoV-2 genomic surveillance network'. Together they form a unique fingerprint.

Cite this